Peptides and longevity research, without promises
Aging-biology research asks how aging works in cells and animals. Two peptides people often ask about here are epitalon and MOTS-c. We make no statement about their effects on aging in people. If you searched for “peptides for longevity”, this is the page for that research area.
- Evidence grade or review status for every compound
- Sources listed on every page
- US and sport status, dated
Epitalon and MOTS-c are two peptides people often ask about in connection with aging. No study we have reviewed shows an effect on aging in people, and neither compound is approved by the FDA. The MOTS-c studies in our register are in mice and in cells; our review of epitalon's human research is not finished.
Compounds studied in this area
Grades describe the published evidence, not a promise of any effect.
What can’t we say about epitalon and MOTS-c?
Saying what we don't know is part of the evidence.
Any effect on aging in people. No study we have reviewed shows one, and our review of epitalon's human research is not finished.
That either compound is approved by the FDA. Neither is.
Are epitalon and MOTS-c FDA-approved medicines? US and sport status
As of November 2026. See the full tracker and the changelog.
| Compound | FDA approval | 503A compounding (2026) | WADA (2026 List) |
|---|---|---|---|
| Epitalon | Not approved | FDA advisory committee voted for listing (Jul); HHS enforcement-discretion policy (Oct); no rule yet | Not named; S0 covers unapproved substances |
| MOTS-c | Not approved | FDA advisory committee voted for listing (Jul); HHS enforcement-discretion policy (Oct); no rule yet | Prohibited (S4.4.1, named) |
Worth knowing
Research use only
None of the compounds on this page is an FDA-approved medicine. Nothing on this page is medical advice or describes use in people.
What research use only meansNo doses, ever
We publish no doses, protocols, or cycles for people, on any page.
Why we publish no dosesHow we grade evidence
Grades follow study design: cell and animal studies (preclinical), small human studies, then controlled human trials, with approval tracked separately. A grade is not a promise of any effect.
Evidence gradesQuestions people ask
Does any peptide on this page slow aging in people?
We make no such statement. No study we have reviewed shows an effect on aging in people, and neither compound is approved by the FDA.
Is NAD+ a peptide?
No. NAD+ is a coenzyme made of two nucleotides, not a chain of amino acids. Our NAD+ guide explains what it is and where regulators stand.
Sources
- Lee C, et al. [Cell and mouse study of MOTS-c, a peptide encoded in mitochondrial DNA.] Cell Metab. 2015;21(3):443–454. PMID 25738459. doi.org/10.1016/j.cmet.2015.02.009
- U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting page, 23–24 July 2026: agenda, voting questions and FDA briefing (no minutes posted as of 17 November 2026). www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
- U.S. Department of Health and Human Services. Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, 28 Oct 2026. www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy.pdf
- World Anti-Doping Agency. Prohibited List 2026 (in force 1 January 2026) and 2027 (in force 1 January 2027). www.wada-ama.org/en/prohibited-list
- U.S. Department of Health and Human Services. Enforcement discretion policy, Appendix B: peptide identities and justifications, October 2026 (records the July 2026 committee outcome for each of the six peptides). www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf
- ClinicalTrials.gov. NCT07505745: placebo-controlled phase 2 trial of MOTS-c in adults with prediabetes and overweight or obesity (recruiting; no results). clinicaltrials.gov/study/NCT07505745
Start with the evidence
Every page sourced and dated, including what the research does not show.
Open the research library